Patrick M. Shea
Algemeen Directeur bij Intrance Medical Systems, Inc.
Actieve functies van Patrick M. Shea
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Intrance Medical Systems, Inc.
 Intrance Medical Systems, Inc. Pharmaceuticals: MajorHealth Technology Intrance Medical Systems, Inc. is a company focused on developing and commercializing clinical products for the treatment of advanced Parkinson's disease. The company is based in Albany, NY. Recently, the company appointed Ashley Prange as Vice President of Business Development to strengthen its focus on strategic partnerships, including out-licensing activities and commercial collaborations. Parkinson's disease is the second most common neurodegenerative disorder, affecting nearly one million people in the United States. The company was founded in 2018 by Ulf Rosén and Roger Bolsöy. The CEO is Patrick M. Shea. | Directeur/Bestuurslid | 13-05-2021 | - |
| Algemeen Directeur | 13-05-2021 | - |
Loopbaan van Patrick M. Shea
Eerdere bekende functies van Patrick M. Shea
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OSI PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 10-06-2010 | - |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Intrance Medical Systems, Inc.
Intrance Medical Systems, Inc. Pharmaceuticals: MajorHealth Technology Intrance Medical Systems, Inc. is a company focused on developing and commercializing clinical products for the treatment of advanced Parkinson's disease. The company is based in Albany, NY. Recently, the company appointed Ashley Prange as Vice President of Business Development to strengthen its focus on strategic partnerships, including out-licensing activities and commercial collaborations. Parkinson's disease is the second most common neurodegenerative disorder, affecting nearly one million people in the United States. The company was founded in 2018 by Ulf Rosén and Roger Bolsöy. The CEO is Patrick M. Shea. | Health Technology |
- Beurs
- Insiders
- Patrick M. Shea
- Ervaring
